Harvard Pulmonary And Critical Care Medicine 2023

70 $

+ Include: 61 videos + 51 pdfs, size: 19.6 GB

+ Target Audience: pulmonology physician, critical care physician

Description

+ Include: 61 videos + 51 pdfs, size: 19.6 GB

+ Target Audience: pulmonology physician, critical care physician

+ Sample video: contact me for sample video

+ Information:

Schedule : April 23 – 27, 2023

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2023 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

  • Post-acute sequelae of COVID-19
  • Chronic cough
  • COPD
  • Asthma
  • Lung nodules
  • Lung cancer
  • Sleep-disordered breathing
  • GERD
  • Sepsis
  • ARDS
  • Sarcoidosis
  • IPF
  • Pleural disease
  • Pneumonia
  • Tuberculosis
  • Surgical emergencies
  • Thromboembolism
  • Lung transplantation
  • Neurologic issues in the ICU
  • Septic shock
  • Interstitial lung disease
  • Bronchiectasis
  • Cystic fibrosis
  • Atypical mycobacterial disease
  • Pulmonary hypertension
  • Cardiopulmonary disorders
  • Complications from cardiac arrest
  • Hypersensitivity pneumonitis
  • Occupational and environmental lung disease
  • Acute respiratory failure
  • Vaping-related lung disease
  • Hemorrhage and ANCA-associated disease

REASONS TO ATTEND IN 2023

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

  • COVID-19, PASC, and emerging diseases
  • Advanced techniques in interventional pulmonology
  • High-flow oxygen therapy for respiratory failure
  • New biologics for asthma
  • Lung microbiome: emerging implications for lung health
  • Emerging evidence for targeted temperature management
  • Evaluating occupational and environmental lung disease
  • Prescribing medications for interstitial lung disease
  • Pulmonary embolus: the latest treatment strategies
  • State-of-the-art management of the critically ill patient
  • Guidance to conduct end-of-life discussions
  • Updates in pulmonary pathology
  • New treatment options in cystic fibrosis
  • Handling neurologic and surgical emergencies in the medical ICU
  • The state of the art in interventional bronchoscopy
  • The most current guidelines for treating sepsis
  • Evidence-based treatment of ARDS
  • Updates on vaping-related lung disease
  • New therapeutics in the age of immunology
  • Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
  • New approaches that improve outcomes for patients with unexplained chronic cough
  • Current guidelines for management of pulmonary nodules
  • Targeted therapies and immunotherapies for lung cancer
  • When to consider lung transplantation and eligibility
  • When and how to use the newest drugs in IPF
  • Expert advice on atypical mycobacterial diagnostics and therapy
  • New concepts in the use of vasopressors in septic shock
  • New drugs and combinations in pulmonary hypertension
  • New evidence on sedation, analgesia, and early mobility
  • Point-of-care pulmonary ultrasound in the intensive care unit

 

+ Topics:

Day 1 Cystic Fibrosis and Bronchiectasis Understanding CFTR and New Treatment – Isabel Neuringer, MD.mp4
Day 1 Cystic Fibrosis and Bronchiectasis Understanding CFTR and New Treatment – Isabel Neuringer, MD.pdf
Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs – Sydney Montesi, MD.mp4
Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs – Sydney Montesi, MD.pdf
Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD – Barry Shea, MD.mp4
Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD – Barry Shea, MD.pdf
Day 1 GERD in Pulmonology – David J. Kanarek, MD.mp4
Day 1 GERD in Pulmonology – David J. Kanarek, MD.pdf
Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! – Rachel Knipe, MD.mp4
Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! – Rachel Knipe, MD.pdf
Day 1 Lung Transplantation Referral, Patient Selection, Lung Allocation and COVID – Brian Keller, MD.mp4
Day 1 Lung Transplantation Referral, Patient Selection, Lung Allocation and COVID – Brian Keller, MD.pdf
Day 1 New Approaches to the Unexplained Chronic Cough – Kai Saukkonen, MD.mp4
Day 1 New Approaches to the Unexplained Chronic Cough – Kai Saukkonen, MD.pdf
Day 1 Occupational and Environmental Lung Disease – L. Christine Oliver, MD.mp4
Day 1 Occupational and Environmental Lung Disease – L. Christine Oliver, MD.pdf
Day 1 Palliative Care in Advanced Lung Disease – Bethany-Rose Daubman, MD.mp4
Day 1 Palliative Care in Advanced Lung Disease – Bethany-Rose Daubman, MD.pdf
Day 1 Pulmonary Pathology Interstitial Lung Disease – Lida Hariri, MD, PhD.mp4
Day 1 Pulmonary Pathology Interstitial Lung Disease – Lida Hariri, MD, PhD.pdf
Day 1 Q _ A Session with Speakers – Drs. Daubman, Hallowell, Hariri, Knipe, Shea, and Kathryn Hibbert, MD.mp4
Day 1 Q _ A Session with Speakers – Drs. Kanarek, Keller, Lai, Neuringer, Oliver, Saukkonen, and Angela Frank, MD, MPH.mp4
Day 1 The Microbiome and Lung Disease – Peggy Lai, MD.mp4
Day 1 The Microbiome and Lung Disease – Peggy Lai, MD.pdf
Day 1 Treatment Challenges of Pulmonary Sarcoidosis – Robert Hallowell, MD.mp4
Day 1 Treatment Challenges of Pulmonary Sarcoidosis – Robert Hallowell, MD.pdf
Day 1 Welcome – David J. Kanarek, MD.mp4
Day 2 Approach to the Immunocompromised Critically Ill Patient – Lisa Bebell, MD.mp4
Day 2 Approach to the Immunocompromised Critically Ill Patient – Lisa Bebell, MD.pdf
Day 2 ARDS State-of-the-Art Strategies to Protect the Lung – Kathryn Hibbert, MD.mp4
Day 2 ARDS State-of-the-Art Strategies to Protect the Lung – Kathryn Hibbert, MD.pdf
Day 2 COVID-19 Novel Therapeutics and New Developments – Alyssa Letourneau, MD.mp4
Day 2 COVID-19 Novel Therapeutics and New Developments – Alyssa Letourneau, MD.pdf
Day 2 Critical Care Echo 2.0 The Whys and Hows of Assessing Cardiac Output – Jonah Rubin, MD.mp4
Day 2 Critical Care Echo 2.0 The Whys and Hows of Assessing Cardiac Output – Jonah Rubin, MD.pdf
Day 2 Emerging Infectious Diseases – Paul Biddinger, MD.mp4
Day 2 Emerging Infectious Diseases – Paul Biddinger, MD.pdf
Day 2 Expanded Q _ A Session – Drs. Alba, Bebell, Biddinger, Christiani, Ginns, Hibbert, and Letourneau.mp4
Day 2 Fluid Responsiveness – Alexandra Wong, MD.mp4
Day 2 Fluid Responsiveness – Alexandra Wong, MD.pdf
Day 2 Looking Ahead New Discoveries and Ongoing Investigation into PASC – George Alba, MD.mp4
Day 2 Looking Ahead New Discoveries and Ongoing Investigation into PASC – George Alba, MD.pdf
Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May Not Be Best – Carolyn La Vita, MHA, RRT.mp4
Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May Not Be Best – Carolyn La Vita, MHA, RRT.pdf
Day 2 Novel Ventilator Modes The Hype and Reality – Carolyn La Vita, MHA, RRT.mp4
Day 2 Novel Ventilator Modes The Hype and Reality – Carolyn La Vita, MHA, RRT.pdf
Day 2 Q _ A with Speakers – Drs. Kanarek, North, Rubin, and Wong, and Carolyn La Vita, MHA, RRT.mp4
Day 2 The Legacy of COVID A Clinical Approach to Post-Acute Sequelae of COVID – Leo Ginns, MD.mp4
Day 2 The Legacy of COVID A Clinical Approach to Post-Acute Sequelae of COVID – Leo Ginns, MD.pdf
Day 2 Vaping-Associated Acute Lung Injury – David Christiani, MD, MPH, MS.mp4
Day 2 Vaping-Associated Acute Lung Injury – David Christiani, MD, MPH, MS.pdf
Day 2 Vasopressors in Septic Shock Old Friends and New – Jason Griffith, MD, PhD.mp4
Day 2 Vasopressors in Septic Shock Old Friends and New – Jason Griffith, MD, PhD.pdf
Day 3 Common Neurologic Issues in the ICU – Sahar Zafar, MD.mp4
Day 3 Common Neurologic Issues in the ICU – Sahar Zafar, MD.pdf
Day 3 Exercise and Cardiopulmonary Disorders Indications and Interpretation – C. Corey Hardin, MD, PhD.mp4
Day 3 Exercise and Cardiopulmonary Disorders Indications and Interpretation – C. Corey Hardin, MD, PhD.pdf
Day 3 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis – Eric Schmidt, MD.mp4
Day 3 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis – Eric Schmidt, MD.pdf
Day 3 Prognosis and Uncertainty in the ICU – Emily Rubin, MD.mp4
Day 3 Prognosis and Uncertainty in the ICU – Emily Rubin, MD.pdf
Day 3 Pulmonary Embolism An Update – Alison Witkin, MD.mp4
Day 3 Pulmonary Embolism An Update – Alison Witkin, MD.pdf
Day 3 Pulmonary Hypertension Evaluation and Management – Josanna Rodriguez-Lopez, MD.mp4
Day 3 Pulmonary Hypertension Evaluation and Management – Josanna Rodriguez-Lopez, MD.pdf
Day 3 Q _ A with Speakers – Drs. Frank, Greer, Griffith, Rubin, Saillant, Schmidt, and Zafar.mp4
Day 3 Q _ A with Speakers – Drs. Hardin, Hibbert, Niles, Rodriguez-Lopez, Rosovsky, and Witkin.mp4
Day 3 Sedation, Analgesia and Early Mobility The State of the Art in 2023 – Crystal North, MD, MPH.mp4
Day 3 Sedation, Analgesia and Early Mobility The State of the Art in 2023 – Crystal North, MD, MPH.pdf
Day 3 Surgical Emergencies in the Medical ICU – Noelle Saillant, MD.mp4
Day 3 Surgical Emergencies in the Medical ICU – Noelle Saillant, MD.pdf
Day 3 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2023 – Rachel Rosovsky, MD, MPH.mp4
Day 3 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2023 – Rachel Rosovsky, MD, MPH.pdf
Day 3 TTM and Neuroprognostication after Cardiac Arrest – David Greer, MD.mp4
Day 3 TTM and Neuroprognostication after Cardiac Arrest – David Greer, MD.pdf
Day 3 Vasculitis and ANCA – John Niles, MD.mp4
Day 3 Vasculitis and ANCA – John Niles, MD.pdf
Day 4 A Strategic Approach to the Management of Pulmonary Nodules – Angela Frank, MD, MPH.mp4
Day 4 A Strategic Approach to the Management of Pulmonary Nodules – Angela Frank, MD, MPH.pdf
Day 4 Asthma Ensuring Your Treatment Approaches Are Current with the State of the Art – Jehan Alladina, MD.mp4
Day 4 Asthma Ensuring Your Treatment Approaches Are Current with the State of the Art – Jehan Alladina, MD.pdf
Day 4 Community-Acquired Pneumonia The Newest Guidelines and State-of-the-Art Treatment Strategies – Joshua Metlay, MD, PhD.mp4
Day 4 Community-Acquired Pneumonia The Newest Guidelines and State-of-the-Art Treatment Strategies – Joshua Metlay, MD, PhD.pdf
Day 4 COPD 2023 – Walter O_Donnell, MD.mp4
Day 4 COPD 2023 – Walter O_Donnell, MD.pdf
Day 4 Extended Q _ A with Interventional Pulmonary Faculty – Drs. Folch, Frank, Keyes, and Kheir.mp4
Day 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond – Colleen Keyes, MD, MPH.mp4
Day 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond – Colleen Keyes, MD, MPH.pdf
Day 4 Interventional Pulmonology in 2023 – Erik Folch, MD.mp4
Day 4 Interventional Pulmonology in 2023 – Erik Folch, MD.pdf
Day 4 Looking Deeper Patterns and Insights from Chest Radiology – Amita Sharma, MBBS.mp4
Day 4 Looking Deeper Patterns and Insights from Chest Radiology – Amita Sharma, MBBS.pdf
Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy – Benjamin Medoff, MD.mp4
Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy – Benjamin Medoff, MD.pdf
Day 4 Non-Tuberculous Mycobacterial Disease Navigating the Labyrinth – Roci’o Hurtado, MD, DTM_H.mp4
Day 4 Non-Tuberculous Mycobacterial Disease Navigating the Labyrinth – Roci’o Hurtado, MD, DTM_H.pdf
Day 4 Pleural Disease 2023 Updates – Fayez Kheir, MD, MSc.mp4
Day 4 Pleural Disease 2023 Updates – Fayez Kheir, MD, MSc.pdf
Day 4 Q_A with Speakers – Drs. Alladina, Farhat, Frank, Hibbert, Hurtado, Medoff, Metlay, Montesi, O_Donnell, Schneider, and Sha.mp4
Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies – Jaime Schneider,.mp4
Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies – Jaime Schneider,.pdf
Day 4 Tuberculosis in 2023 – Maha Farhat, MD, MSc.mp4
Day 4 Tuberculosis in 2023 – Maha Farhat, MD, MSc.pdf
Day 5 Central Sleep Apnea 2023 – James Mojica, MD, FAASM.mp4
Day 5 Central Sleep Apnea 2023 – James Mojica, MD, FAASM.pdf
Day 5 Noninvasive Ventilation for Neuromuscular Disorders and Alveolar Hypoventilation Syndromes – Katherine Dudley, MD.mp4
Day 5 Noninvasive Ventilation for Neuromuscular Disorders and Alveolar Hypoventilation Syndromes – Katherine Dudley, MD.pdf
Day 5 Obstructive Sleep Apnea – James Mojica, MD, FAASM.mp4
Day 5 Obstructive Sleep Apnea – James Mojica, MD, FAASM.pdf
Day 5 Q _ A Session – Drs. Dudley, Kanarek, and Mojica.mp4
Day 5 Sleep Diagnostics – Katherine Dudley, MD.mp4
Day 5 Sleep Diagnostics – Katherine Dudley, MD.pdf

Reviews

There are no reviews yet.

Be the first to review “Harvard Pulmonary And Critical Care Medicine 2023”

Your email address will not be published. Required fields are marked *